You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR LITHOSTAT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LITHOSTAT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02670889 ↗ Manipulating the Gut Microbiome Study Terminated Children's Hospital of Philadelphia Phase 1/Phase 2 2017-03-24 The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders
NCT02670889 ↗ Manipulating the Gut Microbiome Study Terminated Data Management and Coordinating Center (DMCC) Phase 1/Phase 2 2017-03-24 The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders
NCT02670889 ↗ Manipulating the Gut Microbiome Study Terminated Nicholas Ah Mew Phase 1/Phase 2 2017-03-24 The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders
NCT03181828 ↗ Manipulating the Gut Microbiome Study Terminated Nicholas Ah Mew Phase 1/Phase 2 2017-03-24 The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LITHOSTAT

Condition Name

Condition Name for LITHOSTAT
Intervention Trials
Urea Cycle Disorder 2
Argininosuccinate Synthetase Deficiency (Citrullinemia) 1
Argininosuccinic Acid Lyase Deficiency (Argininosuccinic Aciduria) 1
Carbamyl-Phosphate Synthase I Deficiency 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LITHOSTAT
Intervention Trials
Urea Cycle Disorders, Inborn 2
Ornithine Carbamoyltransferase Deficiency Disease 1
Citrullinemia 1
Argininosuccinic Aciduria 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LITHOSTAT

Trials by Country

Trials by Country for LITHOSTAT
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LITHOSTAT
Location Trials
District of Columbia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LITHOSTAT

Clinical Trial Phase

Clinical Trial Phase for LITHOSTAT
Clinical Trial Phase Trials
Phase 1/Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LITHOSTAT
Clinical Trial Phase Trials
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LITHOSTAT

Sponsor Name

Sponsor Name for LITHOSTAT
Sponsor Trials
Nicholas Ah Mew 2
Children's Hospital of Philadelphia 1
Data Management and Coordinating Center (DMCC) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LITHOSTAT
Sponsor Trials
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.